These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 38297152)

  • 1. The role of autophagy in prostate cancer and prostatic diseases: a new therapeutic strategy.
    Lemos G; Fernandes CMAS; Silva FH; Calmasini FB
    Prostate Cancer Prostatic Dis; 2024 Jun; 27(2):230-238. PubMed ID: 38297152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress parameters in patients with prostate cancer, benign prostatic hyperplasia and asymptomatic inflammatory prostatitis: A prospective controlled study.
    Kaya E; Ozgok Y; Zor M; Eken A; Bedir S; Erdem O; Ebiloglu T; Ergin G
    Adv Clin Exp Med; 2017 Oct; 26(7):1095-1099. PubMed ID: 29211357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.
    De Nunzio C; Kramer G; Marberger M; Montironi R; Nelson W; Schröder F; Sciarra A; Tubaro A
    Eur Urol; 2011 Jul; 60(1):106-17. PubMed ID: 21497433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy.
    Zeng J; Liu W; Fan YZ; He DL; Li L
    Theranostics; 2018; 8(1):109-123. PubMed ID: 29290796
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnostic investigations of canine prostatitis incidence together with benign prostate hyperplasia, prostate malignancies, and biochemical recurrence in high-risk prostate cancer as a model for human study.
    Shafiee R; Shariat A; Khalili S; Malayeri HZ; Mokarizadeh A; Anissian A; Ahmadi MR; Hosseini E; Naderafif M; Mohsenzadeh S; Rasoulian MH; Rezapour R; Pourzaer M
    Tumour Biol; 2015 Apr; 36(4):2437-45. PubMed ID: 25420908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin exacerbated high glucose-induced epithelial-mesenchymal transition in prostatic epithelial cells BPH-1 and prostate cancer cells PC-3 via MEK/ERK signaling pathway.
    Yang T; Zhou Y; Wang H; Chen S; Shen M; Hu Y; Wang T; Liu J; Jiang Z; Wang Z; Zhu X; Qian S; Yin X; Lu Q
    Exp Cell Res; 2020 Sep; 394(1):112145. PubMed ID: 32561286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation and chronic prostatic diseases: evidence for a link?
    Sciarra A; Di Silverio F; Salciccia S; Autran Gomez AM; Gentilucci A; Gentile V
    Eur Urol; 2007 Oct; 52(4):964-72. PubMed ID: 17618043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the cGMP/PKG/ERK signaling pathway associated with PDE5Is inhibits fibroblast activation by downregulating autophagy in early progressive benign prostatic hyperplasia.
    Jin S; Liu Z; Xiang P; Fu M; Zhang G; Li J; Niu Y
    World J Urol; 2024 May; 42(1):333. PubMed ID: 38761255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of alpha(1)-adrenoceptor (alpha(1)-AR) antagonists on cell proliferation and apoptosis in the prostate: therapeutic implications in prostatic disease.
    Kyprianou N; Chon J; Benning CM
    Prostate Suppl; 2000; 9():42-6. PubMed ID: 11056502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expressions of the androgen receptor in normal prostate, benign prostatic hyperplasia and prostate cancer].
    Zeng R; Liu ZY; Sun YH; Xu CL; Gao X; Jiao L
    Zhonghua Nan Ke Xue; 2010 Nov; 16(11):967-72. PubMed ID: 21218636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy: a stumbling block of androgen inhibition to treat benign prostatic hyperplasia or prostate cancer.
    Zhang L; Zhou J; Fan S; Liang CZ
    Asian J Androl; 2016; 18(4):654-6. PubMed ID: 26208396
    [No Abstract]   [Full Text] [Related]  

  • 12. 5-ARI induces autophagy of prostate epithelial cells through suppressing IGF-1 expression in prostate fibroblasts.
    Yang BY; Jiang CY; Dai CY; Zhao RZ; Wang XJ; Zhu YP; Qian YX; Yin FL; Fu XY; Jing YF; Han BM; Xia SJ; Ruan Y
    Cell Prolif; 2019 May; 52(3):e12590. PubMed ID: 30883989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autopsy study of prostatic weight and lesions in LUTH: a 12 month prospective study.
    Erinomo OO; Anunobi CC; Orah NO
    Nig Q J Hosp Med; 2013; 23(2):85-9. PubMed ID: 24579501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of IL-17A, E, and F and their receptors in human prostatic cancer: Comparison with benign prostatic hyperplasia.
    Liu Y; Zhao X; Sun X; Li Y; Wang Z; Jiang J; Han H; Shen W; Corrigan CJ; Sun Y
    Prostate; 2015 Dec; 75(16):1844-56. PubMed ID: 26356122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of saw palmetto fruit extract in the treatment of prostate diseases].
    Zhan XX; Shang XJ; Huang YF
    Zhonghua Nan Ke Xue; 2015 Sep; 21(9):841-6. PubMed ID: 26552220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of prostate cancer gene 3 score, prostate health index and percentage free prostate-specific antigen for differentiating histological inflammation from prostate cancer and other non-neoplastic alterations of the prostate at initial biopsy.
    De Luca S; Passera R; Bollito E; Manfredi M; Scarpa RM; Sottile A; Randone DF; Porpiglia F
    Anticancer Res; 2014 Dec; 34(12):7159-65. PubMed ID: 25503144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of Low density lipoprotein Receptor-related Protein 1 (LRP-1) and matrix metalloproteinase-9 (MMP-9) in prostate gland: From normal to malignant lesions.
    Gilardoni MB; Remedi MM; Oviedo M; Dellavedova T; Sarría JP; Racca L; Dominguez M; Pellizas CG; Donadio AC
    Pathol Res Pract; 2017 Jan; 213(1):66-71. PubMed ID: 27931798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preneoplastic prostate lesions: an opportunity for prostate cancer prevention.
    Nelson WG; De Marzo AM; Deweese TL; Lin X; Brooks JD; Putzi MJ; Nelson CP; Groopman JD; Kensler TW
    Ann N Y Acad Sci; 2001 Dec; 952():135-44. PubMed ID: 11795433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal androgen receptor roles in the development of normal prostate, benign prostate hyperplasia, and prostate cancer.
    Wen S; Chang HC; Tian J; Shang Z; Niu Y; Chang C
    Am J Pathol; 2015 Feb; 185(2):293-301. PubMed ID: 25432062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat Shock Proteins in Benign Prostatic Hyperplasia and Prostate Cancer.
    Ratajczak W; Lubkowski M; Lubkowska A
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.